Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Appert Flory

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 7, 2010
[Type 2N von Willebrand disease (Normandy)]F Monpoux, P Brunet, F Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 25, 2010
Measurement of factor VIII activity using one-stage clotting assay: a calibration curve has not to be systematically included in each runS Lattes, A Appert-Flory, F Fischer, et al.
Pathologie-Biologie|September 9, 2010
[Activated partial thromboplastin time prolongation in paediatrics. Retrospective monocentric study at the Nice University Hospital]J Benadiba, F Monpoux, A Appert-Flory, et al.
International Journal of Laboratory Hematology|May 18, 2016
In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficienciesP Toulon, Y Eloit, M Smahi, et al.
Presse Medicale (Paris, France : 1983)|November 5, 1997
[Cerebral vascular complication of hyperhomocysteinemia. Controlling thromboembolic complications with folates]M Candito, P Bedoucha, D Jambou, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 7, 2010
[Type 2N von Willebrand disease (Normandy)]F Monpoux, P Brunet, F Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 25, 2010
Measurement of factor VIII activity using one-stage clotting assay: a calibration curve has not to be systematically included in each runS Lattes, A Appert-Flory, F Fischer, et al.
Pathologie-Biologie|September 9, 2010
[Activated partial thromboplastin time prolongation in paediatrics. Retrospective monocentric study at the Nice University Hospital]J Benadiba, F Monpoux, A Appert-Flory, et al.
International Journal of Laboratory Hematology|May 18, 2016
In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficienciesP Toulon, Y Eloit, M Smahi, et al.
Presse Medicale (Paris, France : 1983)|November 5, 1997
[Cerebral vascular complication of hyperhomocysteinemia. Controlling thromboembolic complications with folates]M Candito, P Bedoucha, D Jambou, et al.
Pageof 1